https://scholars.lib.ntu.edu.tw/handle/123456789/610527
標題: | The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma | 作者: | Huang, Yen-Hsiang Hsu, Kuo-Hsuan Chin, Chun-Shih Tseng, Jeng-Sen Yang, Tsung-Ying Chen, Kun-Chieh KANG-YI SU SUNG-LIANG YU Chen, Jeremy J W Chang, Gee-Chen |
關鍵字: | Adenocarcinoma; Bevacizumab; ErbB receptors; Lung neoplasms; Tyrosine kinase inhibitor | 公開日期: | 四月-2022 | 卷: | 54 | 期: | 2 | 來源出版物: | Cancer research and treatment | 摘要: | The aim of this study was to investigate the efficacy of various epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) plus bevacizumab in advanced EGFR-mutant lung adenocarcinoma patients. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/610527 | ISSN: | 1598-2998 2005-9256 |
DOI: | 10.4143/crt.2021.671 |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。